IndraLab
Statements
reach
"Significant progress is being made on the development of therapeutics targeting USP7 and we direct the reader to recent studies and reviews of this area which we will not cover here.8 9 An early study of USP7 showed that it interacts with infected cell polypeptide 0 (ICP0) to activate Herpes simplex virus type 1 (HSV-1),10 hence the name HAUSP (in this review we refer to the protein as USP7)."